News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
Bis zu 1,65 Millionen Euro für Biotech im All: Sprind startet neue Challenge
The German Federal Agency for Leap Innovations (Sprind) has launched the Orbital BioWorks Challenge and provides European teams with up to 1.65 million euros in non-dilutive funding for the development of biotech and pharmaceutical applications in weightlessness. The application deadline is July 3, 2026.
Sprind Challenge sucht Ideen fürs Metallrecycling
The Sprind Challenge supports innovative processes for recovering critical metals from waste streams. Applications are open until November 7, 2025.
AATec Medical and Sprind cooperate on preclinical study
Munich-based biotech startup AATec Medical is collaborating with the Federal Agency for Disruptive Innovation (Sprind) on drug development. The goal of the cooperation is to test the startup’s first product candidate in various disease models.
Sprind startet Wettbewerb für vollautonome Drohnen
The Federal Agency for Leap Innovations is supporting the development of fully autonomous drones with an innovation competition that fly safely even under adverse conditions and in the presence of various disruptive factors. The application deadline is January 14, 2024.
Reverion receives €3 million Sprind funding
The Federal Agency for Leap Innovations has announced the participants in the second phase of the Sprind Challenge “Long-Duration Energy Storage”. Reverion from Munich is among the four selected startups.
Sprind funding for two Munich biotech startups
Insempra and Global Sustainable Transformation GST have been selected as participants in the Sprind Challenge “Circular Biomanufacturing”. This means the two Munich startups will receive up to 1.5 million euros each over the next 12 months.
Capsitec receives €2.5 million in Sprind funding
The Munich startup Capsitec was selected by the Federal Agency for Leap Innovations for the third and final phase of the Sprind Challenge “Broad-Spectrum Antivirals”. As a result, the biotech company receives funding of €2.5 million for the next twelve months.
Sprind supports laser-driven nuclear fusion with up to 90 million euros
The German federal agency for breakthrough innovations Sprind has founded the subsidiary Pulsed Light Technologies to support startups in the development of laser-driven fusion. Funding of up to 90 million euros is planned.
SPRIND Challenges suchen disruptive Innovationen
The Federal Agency for Radical Innovation (SPRIND) is launching two new innovation competitions in which the development of disruptive technologies will be funded with millions of euros. Applications for the two challenges are possible until October 2 and 16, respectively.